On (b)(6) 2019, a 25mm amplatzer pfo was selected for implant.The patient was recently diagnosed of stroke on (b)(6) 2018.The device was implanted with a 8f troqvue delivery system through the right femoral vein.The physician noticed an unexpected positional adjustment/shift in positioning of the device upon removal of the delivery system.The patient was discharged on (b)(6) 2019 and did well on the one month follow up.On (b)(6) 2020, the patient experiences an ischemic stroke.The patient had left cheek numbness and slurred speech.Symptoms were sudden onset and present constantly for 15 minutes until they resolved on their own.Medication was administered.
|
Additional information for g4, g7, h2, h6, and h10.The device remained implanted.Upon review of the device history records, there were no observed artifacts related to the design, or assembly, or device acceptance inspections that indicate the design or the manufacture of the present occluder is the root cause of the observed transient ischemic attack.The attack occurred four months after the implant procedure in a patient with a history of stroke 11 months prior to the procedure.
|